65
Views
26
CrossRef citations to date
0
Altmetric
Review

Diagnosis and treatment of left-sided prosthetic valve thrombosis

Pages 85-93 | Published online: 10 Jan 2014

References

  • Horstkotte D, Burckhardt D. Prosthetic valve thrombosis. J. Heart Valve Dis.4, 141–153 (1995).
  • Bortolotti U, Milano A, Mossuto E et al. Early and late outcome after reoperation for prosthetic valve dysfunction: analysis of 549 patients during a 26-year period. J. Heart Valve Dis.3, 81–87 (1994).
  • Rizzoli G, Guglielmi C, Toscano G et al. Reoperations for acute prosthetic thrombosis and pannus: an assessment of rates, relationship and risk. Eur. J. Cardiothorac. Surg.16, 74–80 (1999).
  • Durrleman N, Pellerin M, Bouchard D et al. Prosthetic valve thrombosis: twenty-year experience at the Montreal Heart Institute. J. Thorac. Cardiovasc. Surg.278, 1388–1392 (2004).
  • Baille Y, Choffel J, Sicard MP et al. Traitment thrombolytique des thromboses de prosthese valvulaire (letter). Nouv. Presse Med.3, 1233 (1974).
  • Bonow RO, Carabello B, DeLeon AC. ACC/AHA Guidelines for the management of patients with valvular heart disease. J. Am. Coll. Cardiol.32, 1486–1588 (1998).
  • Vahanian A, Baumgartner H, Bax J et al. Guidelines on the management of valvular heart disease. Eur. Heart J.28, 230–268 (2007).
  • Cáceres-Lóriga FM, Pérez-López H, Morlans-Hernández K et al. Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients. J. Thromb. Thrombolysis21, 185–190 (2006).
  • Lengyel M, Vándor L. The role of thrombolysis in the management of left-sided prosthetic valve thrombosis, A study of 85 cases diagnosed by transesophageal echocardiography. J. Heart Valve Dis.10, 636–649 (2001).
  • Lengyel M, Végh G, Vándor L. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis. J. Heart Valve Dis.8, 167–173 (1999).
  • Salem DN, Stein PD, Al-Ahmad A et al. Antithrombotic therapy in valvular heart disease – native and prosthetic. The Seventh ACCP Conference on Antithrombotic and Thrombolytic therapy. Chest126(Suppl.), 457–482S (2004).
  • Silver H, Khan SS, Matlott JM et al. The St-Jude valve. Thrombolysis as first line of therapy for cardiac valve thrombosis. Circulation87, 30–37 (1993).
  • Grunkmeier GL. ‘Our complication rates are lower than theirs’: statistical critique of heart valve complications. J. Thorac. Cardiovasc. Surg.125, 290–300 (2003).
  • Gueret P, Vignon P, Fournier P et al. Transesophageal echocardiography for the diagnosis and management of nonobstructive thrombosis of mechanical mitral valve prosthesis. Circulation91, 103–110 (1959).
  • Malergue MC, Temkine J, Slama M et al. Interest de l’echocardiographia transoesophagienne systematique postopératoira précoce des remplacements valvularies mitraus. Arch. Mal. Coeur Vaiss.85, 1299–1304 (1992).
  • Bemurat LR, Laffort PR, Deville CJ et al. Management of nonobstructive thrombosis of prosthetic mitral valve in asymptomatic patients in the early postoperative period: a study in 20 patients. Echocardiography116, 339–346 (1999).
  • Laplace G, Lafitte S, Labeque JN et al. Clinical significance of early thrombosis after prosthetic mitral valve replacement: a postoperative monocentric study of 680 patients. J. Am. Coll. Cardiol.43, 1283–1290 (2004).
  • Butchart EG, Payne N, Li H-H et al. Better anticoagulation control improves survival after valve replacement. J. Thorac. Cardiovasc. Surg.23, 715–723 (2002).
  • DeSanto LS, Romano G, Della Corte A et al. Mitral mechanical replacement in young rheumatic women: analysis of long-term survival, valve related complications and pregnancy outcomes over a 3707-patient-year follow-up. J. Thorac. Cardiovasc. Surg.130, 13–19 (2005).
  • De Caterina R, Husted S, Wallentin L. Agnelli G, Bachmann F et al. Anticoagulants in heart disease: current status and perspectives. Eur. Heart J.28, 880–913 (2007).
  • Hurrell DG, Schaff HV, Tajik J. Thrombolytic therapy for obstruction of mechanical prosthetic valves. Mayo Clin. Proc.71, 605–613 (1996).
  • Shapira Y, Herz I, Vaturi M et al. Thrombolysis is an effective and safe therapy in stuck bileaflet mitral valves in the absence of high-risk thrombi. J. Am. Coll. Cardiol.35, 1874–1780 (2000).
  • Fritzsche D, Eitz T, Minami K et al. Digital frequency analysis of valve sound phenomena in patients after prosthetic valve surgery: its capability for a true home monitoring of valve function. J. Heart Valve Dis.14, 657–663 (2005).
  • Horstkotte D. Point-of-care devices to improve long-term prognosis after valve replacedment. J. Heart Valve Dis.14, 472–475 (2005).
  • Cannegieter SC, Rosendall FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation89, 635–641 (1994).
  • Rahimtoola SH. The problem of valve prosthesis–patient mismatch. Circulation58, 20–24 (1978).
  • Montorsi P, Cavoretto D, Parolari A et al. Diagnosing prosthetic mitral valve thrombossi and the effect of the type of prosthesis. Am. J. Cardiol.90, 73–76 (2002).
  • Montorsi P, DeBernardi F, Muratori M et al. Role of cine-fluoroscopy, transthoracic, and transesophageal echocardiography in patients with suspected heart valve thrombosis. Am. J. Cardiol.85, 58–64 (2000).
  • Montorsi P, Caboretto D, Alimento M et al. Prosthetic valve thrombosis. Can fluoroscopy predict the efficacy of thrombolytic treatment? Circulation108, II79–II84 (2003).
  • Czer LSC, Weiss M, Bateman TM et al. Fibrinolytic therapy of St. Jude valve thrombosis under guidance of digital cinefluoroscopy. J. Am. Coll. Cardiol.5, 1244–1249 (1985).
  • Piper C, Hering D, Horstkotte D. Prosthetic valve thrombosis: predisposition and diagnosis. Eur. Heart J.3(Suppl. Q), Q16–Q22 (2001).
  • Deviri E, Sareli P, Wisenbaugh T, Cronje SL. Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management. J. Am. Coll. Cardiol.17, 646–650 (1991).
  • Barbetsas J, Nagueh SF, Pitsavos C et al. Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical transthoracic and transesophageal echocardiographic parameters. J. Am. Coll. Cardiol.32, 1410–1417 (1998).
  • Hering D, Piper C, Horstkotte D. Management of prosthetic valve thrombosis. Eur. Heart J.3(Suppl. Q), Q22–Q26 (2001).
  • Delgado C, Bonnin O, Garriga JM et al. Intermittent electromechanical dissociation as an unusual sign of prosthetic valve thrombosis in a patient with prosthetic fibrous ingrowth. J. Am. Soc. Echocardiogr.13, 685–689 (2000).
  • Gupta D, Kothari SSS, Bahl VK et al. Thrombolytic therapy for prosthetic valve thrombosis: short and long-term results. Am. Heart J.140, 906–916 (2000).
  • Lengyel M. Management of prosthetic valve thrombosis. J. Heart Valve Dis.13, 329–334 (2004).
  • Habib G, Cornen A, Mesana T et al. Diagnosis of prosthetic heart valve thrombosis. The respective values of transthroacic and transesophageal Doppler echocardiography. Eur. Heart J.14, 447–455 (1993).
  • Muratori M, Montorsi P, Teruzzi G et al. Feasibility and diagnostic accuracy of mechanical prostheses leaflet motion by transthoracic and transesophageal echocardiography in suspected prosthetic valve dysfunction. Am. J. Cardiol.97, 94–100 (2006).
  • Ozkokeli M, Sensoz Y, Ates M, Ekinci A, Akcar M, Yekeler I. Surgical treatment of left-sided prosthetic valve thrombosis: short and long-term results. Int. Heart J.46, 105–111 (2005).
  • Toker ME, Eren E, Balkanay M et al. Multivariate analysis for operative mortality in obstructive prosthetic valve dysfunction due to pannus and thrombus formation. Int. Heart J.47, 237–245 (2006).
  • Lengyel M, Fuster V, Keltai M et al. Guidelines for the management of left-sided prosthetic valve thrombosis: a role for thrombolytic therapy. J. Am. Coll. Cardiol.30, 1521–1526 (1997).
  • Manteiga R, Sonto JC, Altes A et al. Short-course thrombolysis as the first line of therapy for cardiac valve thrombosis. J. Thorac. Cardiovasc. Surg.115, 780–784 (1998).
  • Sugano T, Fujiwara H, Adachi S, Sugimoto K, Amano J, Suzuki A. Tissue-type plasminogen activator (t-PA) lysis of aortic and mitral valve thrombosis. J. Cardiovasc. Surg.34, 259–261 (1993).
  • DeNofrio D, Ament AF, Mark JB, George SE. Accelerated TPA for treatment of prosthetic valve thrombosis. Clin. Cardiol.19, 665–668 (1996).
  • Renzulli A, Vitale N, Caruso A et al. Thrombolysis for prosthetic valve thrombosis: indications and results. J. Heart Valve Dis.6, 212–218 (1997).
  • Roudaut R, Lafitte S, Roudaut M-F et al. Fibrinolysis of mechanical prosthetic valve thrombosis. A single center study of 127 cases. J. Am. Coll. Cardiol.41, 653–658 (2003).
  • Özkan M, Kaymaz C, Kirma C et al. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. J. Am. Coll. Cardiol.35, 1881–1889 (2000).
  • Lengyel M, Horstkotte D, Völler H, Mistiaen WP; Working Group Infection, Thrombosis, Embolism and Bleeding of the Society for Heart Valve Disease. Recommendations for the management of prosthetic valve thrombosis. J. Heart Valve Dis.14, 567–575 (2005).
  • Alpert JS. The thrombosed prosthetic valve. J. Am. Coll. Cardiol.41, 659–660 (2003).
  • Tong AT, Roudaut R, Özkan M et al. Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the International PRO-TEE registry. J. Am. Coll. Cardiol.43, 77–84 (2004).
  • Roudaut R, Labbe T, Lorient-Roudaut M-R et al. Mechanical cardiac valve thrombosis. Is fibrinolysis justified? Circulation86(Suppl. II), II8–II15 (1992).
  • Nagy A, Drénes M, Lengyel M. Success and complication rate of thrombolysis in prosthetic valve thrombosis is not related to thrombus size or NYHA functional class. Eur. J. Echocardiogr.8, S131 (2007).
  • Azpitarte J, Sanchez-Ramos J, Urda T et al. Prosthetic valve thrombosis: which is the most appropriate initial therapy? Rev. Esp. Cardiol.54, 1367–1376 (2001).
  • Nagy A, Lengyel M. TEE guided thrombolysis with or without surgery in prosthetic valve thrombosis. Eur. J. Echocardiogr.7, S1059 (2006) (Abstract).
  • Kurzrok S, Singh AK, Most AS, Williams DO. Thrombolytic therapy for prosthetic cardiac valve thrombosis. J. Am. Coll. Cardiol.9, 592–598 (1987).
  • Vitale N, Renzulli A, Cerasuolo F, et al. Prosthetic valve obstruction: thrombolysis versus operation. Ann. Thorac. Surg.57, 365–370 (1994).
  • Koller PT, Aron KV. Thrombolytic therapy of leftsided prosthetic valve thrombosis. Chest108, 1683–1689 (1995).
  • Bassand JT, Decque O, Bernard Y. Thrombose postoperatoire precoce (10.jour) d’une prothese de Starr-mitrale. Arch. Mal. Coeur Vaiss.75, 349–356 (1982).
  • Munclinger MJ, Patgel JJ, Mitha AS. Thrombolysis of thrombosed St. Jude Medical prosthetic valves: rethrombosis – a sign of tissue ingrowth. J. Thorac. Cardiovasc. Surg.115, 248–249 (1998).
  • Reddy NK, Padmanabhan TNC, Singh S et al. Thrombolysis in left-sided prosthetic valve occlusion: immediate and follow-up results. Ann. Thorac. Surg.58, 462–471 (1994).
  • Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart93, 137–142 (2007).
  • Viedt C, Mereles D, Kuübler W, Krenzer J. Fibrinolytische Therapie bei Thrombose einer Mitralklappenprothese. Z. Kardiol.89, 698–701 (2000).
  • Young E, Shapiro SM, French WJ, Ginzton LE. Use of transesophageal echocardiography during thrombolysis with tissue plasminogen activator of a thrombosed prosthetic mitral valve. J. Am. Soc. Echocardiogr.5, 153–158 (1992).
  • Tissot H, Vergnes C, Rougier P et al. Fibrinolytic treatment with urokinase and streptokinase for recurrent thrombosis in two valve prostheses for the aortic and mitral valves during pregnancy. J. Gynecol. Obstet. Biol. Reprod. (Paris)20, 1093–1096 (1991).
  • Ambarasan C, Kumar VS, Latchumandhas K, Mullasari AS. Successful thrombolysis of prosthetic mitral valve thrombosis in early pregnancy. J. Heart Valve Dis.10, 393–395 (2001).
  • Temkine J, Malergue MC, Berrabha T, Lecompte Y. Thrombose postopératoire asymptomatique d’une valve de Saint-Jude mitrale: traitement par fibrinolyse au rt-PA. Arch. Mal. Coeur Vaiss.84, 413–417 (1991).
  • Witchitz S, Veyrat C, Moisson P et al. Fibrinolytic treatment of thrombus on prosthetic heart valves. Br. Heart J.44, 545–554 (1980).
  • Serpi M, Schmidt KG, Krenz W et al. Thrombolysis of prosthetic heart valve thrombosis using ecombinant tissue plasminogen activator (rt-PA) in infancy and childhood. Z. Kardiol.90, 191–196 (2001).
  • Vasan RS, Kaul U, Sanghvi S et al. Thrombolytic therapy for prosthetic valve thrombosis: a study based on serial Doppler echocardiographic evaluation. Am. Heart J.123, 1575–1580 (1992).
  • Gulati M, Furlong K, DeCara J et al. Thrombolytic therapy of a left-sided prosthetic valve thrombosis without hemodynamic obstruction: a case report. J. Am. Soc. Echocardiogr.14, 1230–1234 (2001).
  • Gagnon RM, Beaudet R, Lemine J et al. Streptokinase thrombolysis of a chronically thrombosed mitral prosthetic valve. Cathet. Cardiovasc. Diagn.10, 5–10 (1984).
  • Birdi I, Angelini GD, Bryan AJ. Thrombolytic therapy for left sided prosthetic heart valve thrombosis. J. Heart Valve Dis.4, 154–159 (1995).
  • Rinaldi CA, Heppel RM, Chambers JB. Treatment of left-sided prosthetic valve thrombosis. Thrombolysis or surgery? J. Heart Valve Dis.11, 839–843 (2001).
  • Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J. Am. Coll. Cardiol.48, e1–148 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.